TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment
Relapse in multiple myeloma (MM) decreases therapy efficiency through unclear mechanisms of chemoresistance. Since our group previously demonstrated that heme oxygenase-1 (HO-1) and Toll-like receptor 4 (TLR4) are two signaling pathways protecting MM cells from the proteasome inhibitor bortezomib (B...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_c8d39cb351654d97b0b17d10102c0ef2 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Grazia Scandura |e author |
| 700 | 1 | 0 | |a Cesarina Giallongo |e author |
| 700 | 1 | 0 | |a Fabrizio Puglisi |e author |
| 700 | 1 | 0 | |a Alessandra Romano |e author |
| 700 | 1 | 0 | |a Nunziatina Laura Parrinello |e author |
| 700 | 1 | 0 | |a Tatiana Zuppelli |e author |
| 700 | 1 | 0 | |a Lucia Longhitano |e author |
| 700 | 1 | 0 | |a Sebastiano Giallongo |e author |
| 700 | 1 | 0 | |a Michelino Di Rosa |e author |
| 700 | 1 | 0 | |a Giuseppe Musumeci |e author |
| 700 | 1 | 0 | |a Roberto Motterlini |e author |
| 700 | 1 | 0 | |a Roberta Foresti |e author |
| 700 | 1 | 0 | |a Giuseppe Alberto Palumbo |e author |
| 700 | 1 | 0 | |a Giovanni Li Volti |e author |
| 700 | 1 | 0 | |a Francesco Di Raimondo |e author |
| 700 | 1 | 0 | |a Daniele Tibullo |e author |
| 245 | 0 | 0 | |a TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment |
| 260 | |b MDPI AG, |c 2022-04-01T00:00:00Z. | ||
| 500 | |a 10.3390/antiox11040767 | ||
| 500 | |a 2076-3921 | ||
| 520 | |a Relapse in multiple myeloma (MM) decreases therapy efficiency through unclear mechanisms of chemoresistance. Since our group previously demonstrated that heme oxygenase-1 (HO-1) and Toll-like receptor 4 (TLR4) are two signaling pathways protecting MM cells from the proteasome inhibitor bortezomib (BTZ), we here evaluated their cross-regulation by a pharmacological approach. We found that cell toxicity and mitochondrial depolarization by BTZ were increased upon inhibition of HO-1 and TLR4 by using tin protoporphyrin IX (SnPP) and TAK-242, respectively. Furthermore, the combination of TAK-242 and BTZ activated mitophagy and decreased the unfolded protein response (UPR) survival pathway in association with a downregulation in HO-1 expression. Notably, BTZ in combination with SnPP induced effects mirroring the treatment with TAK-242/BTZ, resulting in a blockade of TLR4 upregulation. Interestingly, treatment of cells with either hemin, an HO-1 inducer, or supplementation with carbon monoxide (CO), a by-product of HO-1 enzymatic activity, increased TLR4 expression. In conclusion, we showed that treatment of MM cells with BTZ triggers the TLR4/HO-1/CO axis, serving as a stress-responsive signal that leads to increased cell survival while protecting mitochondria against BTZ and ultimately promoting drug resistance. | ||
| 546 | |a EN | ||
| 690 | |a multiple myeloma | ||
| 690 | |a TLR4/HO-1 crosstalk | ||
| 690 | |a mitochondria | ||
| 690 | |a bortezomib | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Antioxidants, Vol 11, Iss 4, p 767 (2022) | |
| 787 | 0 | |n https://www.mdpi.com/2076-3921/11/4/767 | |
| 787 | 0 | |n https://doaj.org/toc/2076-3921 | |
| 856 | 4 | 1 | |u https://doaj.org/article/c8d39cb351654d97b0b17d10102c0ef2 |z Connect to this object online. |